Related references
Note: Only part of the references are listed.Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population-Based Study of 1,355 Adults
Louise J. M. Alferink et al.
HEPATOLOGY (2021)
In Vitro Modulatory Effect of Stevioside, as a Partial Sugar Replacer in Sweeteners, on Human Child Microbiota
Florentina Gatea et al.
MICROORGANISMS (2021)
Alcohol effects on hepatic lipid metabolism
Sookyoung Jeon et al.
JOURNAL OF LIPID RESEARCH (2020)
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron-Wisnewsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
Giljae Lee et al.
NATURE COMMUNICATIONS (2020)
Diet Rich in Simple Sugars Promotes Pro-Inflammatory Response via Gut Microbiota Alteration and TLR4 Signaling
Alena Fajstova et al.
CELLS (2020)
Circulating microbiome in blood of different circulatory compartments
Robert Schierwagen et al.
GUT (2019)
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
Judith Aron-Wisnewsky et al.
GUT (2019)
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu et al.
GUT (2019)
Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers
Nielson T. Baxter et al.
MBIO (2019)
Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
Suzanne R. Sharpton et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2019)
Diet Rich in Animal Protein Promotes Pro-inflammatory Macrophage Response and Exacerbates Colitis in Mice
Klara Kostovcikova et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids
Jian-Mei Li et al.
MICROBIOME (2019)
IMMUNOTHERAPY Antigen-specific immune tolerance in the liver
Derek G. Doherty
NATURE BIOMEDICAL ENGINEERING (2019)
Food Preservatives Induce Proteobacteria Dysbiosis in Human-Microbiota Associated Nod2-Deficient Mice
Lucia Hrncirova et al.
MICROORGANISMS (2019)
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
Jing Yuan et al.
CELL METABOLISM (2019)
Testing for Nonalcoholic Fatty Liver Disease
Yen-Yi Juo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Yi Duan et al.
NATURE (2019)
Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans
Mattea Muller et al.
SCIENTIFIC REPORTS (2019)
IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM
Jason R. Catanzaro et al.
SCIENTIFIC REPORTS (2019)
Human gut microbes are susceptible to antimicrobial food additives in vitro
Lucia Hrncirova et al.
FOLIA MICROBIOLOGICA (2019)
Alcohol, liver disease and the gut microbiota
Jasmohan S. Bajaj
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD
Cyrielle Caussy et al.
HEPATOLOGY (2018)
The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis
Alexander Rodriguez-Palacios et al.
INFLAMMATORY BOWEL DISEASES (2018)
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen et al.
JOURNAL OF HEPATOLOGY (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles et al.
NATURE MEDICINE (2018)
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva et al.
SCIENTIFIC REPORTS (2018)
Complementary Functional Strategy for Modulation of Human Gut Microbiota
Emanuel Vamanu
CURRENT PHARMACEUTICAL DESIGN (2018)
Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach
Federica Del Chierico et al.
HEPATOLOGY (2017)
Meta-analysis of the human gut microbiome from urbanized and pre-agricultural populations
Leonardo Mancabelli et al.
ENVIRONMENTAL MICROBIOLOGY (2017)
Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation
Benoit Chassaing et al.
GUT (2017)
Intestinal fungi contribute to development of alcoholic liver disease
An-Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Vasilios G. Athyros et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Gut microbiome and liver disease
Naga S. Betrapally et al.
TRANSLATIONAL RESEARCH (2017)
Uncovering the trimethylamine-producing bacteria of the human gut microbiota
Silke Rath et al.
MICROBIOME (2017)
Short-chain fatty acids and inulin, but not guar gum, prevent dietinduced obesity and insulin resistance through differential mechanisms in mice
Karolin Weitkunat et al.
SCIENTIFIC REPORTS (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study
Cyriac Abby Philips et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Dysbiosis and the immune system
Maayan Levy et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome
Magar Ghazarian et al.
SCIENCE IMMUNOLOGY (2017)
Diversity of the intestinal microbiota differently affects non-neuronal and atropine-sensitive ileal contractile responses to short-chain fatty acids in mice
Masako YAJIMA et al.
BIOMEDICAL RESEARCH-TOKYO (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
Andrea Kristina Horst et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: A 31P MRS study
S. J. Bawden et al.
CLINICAL NUTRITION (2016)
Mouse and Human Liver Contain Immunoglobulin A-Secreting Cells Originating From Peyer's Patches and Directed Against Intestinal Antigens
Ludovic Moro-Sibilot et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment
Stefano Ballestri et al.
HEPATOLOGY RESEARCH (2016)
Memory CD8+ T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function
Maria L. Balmer et al.
IMMUNITY (2016)
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome
Rachel J. Perry et al.
NATURE (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
OBESITY FACTS (2016)
Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules
Bryan L. Copple et al.
PHARMACOLOGICAL RESEARCH (2016)
Gut Microbiome of Coexisting BaAka Pygmies and Bantu Reflects Gradients of Traditional Subsistence Patterns
Andres Gomez et al.
CELL REPORTS (2016)
Functional Intestinal Bile Acid 7α-Dehydroxylation by Clostridium scindens Associated with Protection from Clostridium difficile Infection in a Gnotobiotic Mouse Model
Nicolas Studer et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
Yu-ming Chen et al.
SCIENTIFIC REPORTS (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury
Peng Chen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Proteobacteria: microbial signature of dysbiosis in gut microbiota
Na-Ri Shin et al.
TRENDS IN BIOTECHNOLOGY (2015)
ER stress induces NLRP3 inflammasome activation and hepatocyte death
C. Lebeaupin et al.
CELL DEATH & DISEASE (2015)
Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway
J. Park et al.
MUCOSAL IMMUNOLOGY (2015)
The Gut Microbiota and Liver Disease
Cristina Llorente et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease
Sonia Michail et al.
FEMS MICROBIOLOGY ECOLOGY (2015)
Immune Tolerance in Liver Disease
Ian N. Crispe
HEPATOLOGY (2014)
Obeticholic Acid, a Farnesoid X Receptor Agonist, Improves Portal Hypertension by Two Distinct Pathways in Cirrhotic Rats
Len Verbeke et al.
HEPATOLOGY (2014)
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Xiang Gao et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Jotham Suez et al.
NATURE (2014)
Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression
Eric W. Rogier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Maria Stepanova et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in Mice
Myung H. Kim et al.
GASTROENTEROLOGY (2013)
Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease
Marialena Mouzaki et al.
HEPATOLOGY (2013)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection?
Richard J. Johnson et al.
JOURNAL OF EQUINE VETERINARY SCIENCE (2013)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis - A Longitudinal Study
Vincent Wai-Sun Wong et al.
PLOS ONE (2013)
Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice
Marco Aurelio Ramirez Vinolo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
Manal F. Abdelmalek et al.
HEPATOLOGY (2012)
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress POTENTIAL ROLE IN FRUCTOSE-DEPENDENT AND -INDEPENDENT FATTY LIVER
Miguel A. Lanaspa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects
MyPhuong T. Le et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Miguel A. Lanaspa et al.
PLOS ONE (2012)
Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome
Mirjana Rajilic-Stojanovic et al.
GASTROENTEROLOGY (2011)
Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis
Yanfei Chen et al.
HEPATOLOGY (2011)
Liver antigen-presenting cells
Ian Nicholas Crispe
JOURNAL OF HEPATOLOGY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria
Chin Wen Png et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
From the metabolic syndrome to NAFLD or vice versa?
Ester Vanni et al.
DIGESTIVE AND LIVER DISEASE (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Jung Sub Lim et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Choline and Risk of Neural Tube Defects in a Folate-fortified Population
Gary M. Shaw et al.
EPIDEMIOLOGY (2009)
Hepatic Regulatory T Cells and Kupffer Cells Are Crucial Mediators of Systemic T Cell Tolerance to Antigens Targeting Murine Liver
Ekaterina Breous et al.
HEPATOLOGY (2009)
Low Counts of Faecalibacterium prausnitzii in Colitis Microbiota
H. Sokol et al.
INFLAMMATORY BOWEL DISEASES (2009)
Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease
Astrid Spruss et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
Erwin Gaebele et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Verena Keitel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice:: Role of endotoxin
Ina Bergheim et al.
JOURNAL OF HEPATOLOGY (2008)
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Marc-Emmanuel Dumas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice
Fuyumi Isayama et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes
JL Raucy et al.
TOXICOLOGICAL SCIENCES (2004)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Share Paper
